Skip to main content
Clinical Trials/JPRN-UMIN000012096
JPRN-UMIN000012096Completed未知

Efficacy of levocarnitine as an add-on treatment to branched-chain amino acid-enriched nutritional supplementation on liver cirrhosis complicated by hepatic encephalopathy -a open-label study - Efficacy of levocarnitine for hepatic encephalopathy

Faculty of Medical Sciences, University of Fukui0 sites40 target enrollmentStarted: October 28, 2013Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
40

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • 1) No administration of other test drugs within 3 months 2) No administration of other branched-chain amino acid enriched supplements 3) Severe concurrent disease 4) Pregnant and lactating females 5) Contraindication for levocarnitine and branched-chain amino acid enriched supplements 6) Inappropriate for entry onto this study in the judgment of the investigator

Investigators

Sponsor
Faculty of Medical Sciences, University of Fukui

Similar Trials